Inhale is outbid for Quadrant Healthcare

INHL, a maker of inhaleable therapeutics which made an offer to acquire Quadrant (LSE:QTH) on Oct. 20 for $60.2 million or 60p per share, said it will not pursue the acquisition due to a higher bid by...